The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease.

Saved in:
Bibliographic Details
Title: The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease.
Authors: Fu J; Columbia University Irving Medical Center, Department of Medicine, New York, NY, USA., Li S; Columbia University Irving Medical Center, Department of Medicine, New York, NY, USA., Ma H; Columbia University Irving Medical Center, Department of Medicine, New York, NY, USA.; Columbia Center for Translational Immunology, New York, NY, USA., Yang J; Columbia University Irving Medical Center, Department of Medicine, New York, NY, USA., Pagnotti GM; Indiana University, Indianapolis, IN, USA.; University of Texas-MD Anderson Cancer Center, Houston, TX, USA., Brown LM; Quantitative Proteomics and Metabolomics Center, Columbia University, New York, NY, USA., Weiss SJ; Department of Internal Medicine, Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA., Mapara MY; Columbia University Irving Medical Center, Department of Medicine, New York, NY, USA.; Columbia Center for Translational Immunology, New York, NY, USA., Lentzsch S; Columbia University Irving Medical Center, Department of Medicine, New York, NY, USA. sl3440@columbia.edu.
Source: Nature communications [Nat Commun] 2023 Jul 17; Vol. 14 (1), pp. 4271. Date of Electronic Publication: 2023 Jul 17.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2041-1723
DOI:10.1038/s41467-023-39769-8